Investment of Technology in Research Institute Company Insgen, Planned Commercialization of Health Functional Foods and New Drug Development
Korea Atomic Energy Research Institute - Inszen Co., Ltd. Technology Investment Agreement Signing Ceremony. From the left, Jaeseop Kim, CEO of Inszen, Wonseok Park, Director of Korea Atomic Energy Research Institute.
[Asia Economy Reporter Kim Bong-su] Anti-diabetic functional foods extracted from banana, bitter melon, and peony, as well as anticancer agents using moringa export products, have entered the commercialization stage.
The Korea Atomic Energy Research Institute announced on the 1st that it signed a technology investment contract on the 28th of last month to establish a research institute company with Inszen, investing the technology of "anti-diabetic and anticancer substances using bio/food and pharmaceutical materials."
Previously, Dr. Jeong Il-rae, affiliated with the institute, developed the "technology for manufacturing natural product-derived anti-diabetic functional foods mixed with banaba, bitter melon, and peony" and the "technology for manufacturing oral anticancer candidate substances using water-soluble extracts derived from the moringa plant." Both technologies demonstrated excellent anti-diabetic and anticancer effects respectively through animal experiments.
The anti-diabetic functional food, derived from natural ingredients, is non-toxic and showed excellent improvement effects on various causes of type 2 diabetes, which fails to regulate blood sugar. The anticancer candidate substance using moringa extract showed anticancer effects on liver cancer, skin cancer, and breast cancer. When orally administered to mice with malignant non-small cell lung cancer, it demonstrated a remarkable anticancer effect by eliminating more than 95% of tumors.
Based on this technology, Inszen plans to immediately launch health functional foods and develop proprietary natural product new drugs through subsequent clinical trials.
Inszen is a subsidiary of Apimez, a natural product health functional food and new drug development subsidiary of InscoBi, a KOSPI-listed company. Through this contract, it has newly launched as a research institute company of the Atomic Energy Research Institute.
The institute invested the technology, Apimez invested cash, and Korea Science and Technology Holdings and private investment associations are expected to invest additional cash. An agreement on the establishment and operation of a multi-party research institute company was also signed simultaneously on the same day.
A research institute company is a company established within one of the five special zones nationwide with the approval of the Minister of Science and ICT to directly commercialize technology by public research institutions under the "Special Act on the Promotion of Research and Development Special Zones." Korea Science and Technology Holdings, which invested cash this time, is a joint technology holding company funded by 17 government-funded research institutes to promote the commercialization of research achievements.
Inszen is the sixth research institute company invested by the institute. Starting with Colma B&H, the first research institute company in Korea in 2006, it has successively launched research institute companies such as Seoul Propolis, Dukem Bio Research Institute, AcuScan, and Ravi.
Dr. Jeong said, "Based on the developed technology, we will be able to develop high value-added new drugs and improve the health of diabetes and cancer patients."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
